More than two years after an initial FDA approval in melanoma, Bristol Myers Squibb is moving its PD-1/LAG-3 combo Opdualag into registrational testing in one of the most important oncology disease ...
Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). In this ongoing phase 3, multicenter, randomized, ...
Montreal, Quebec--(Newsfile Corp. - September 9, 2025) - Manganese X Energy Corp. (MN:CA) (FSE: 9SC) (TRADEGATE: 9SC) (OTCQB: MNXXF) ("Manganese X" or the "Company") is pleased to announce it is ...
A promising solid-state battery developed in China has entered its final testing phase, marking a major milestone for ...
Lorna Ewart has long been frustrated by the mismatch between animal and human toxicity data. All too often preclinical studies in rats and dogs will suggest a drug is safe, only for clinical trial ...
The successful completion of cold functional testing of Xudabao Nuclear Power Plant’s unit 3 means it can move from the installation phase to the commissioning phase. (Image: CNNC) China National ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results